This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Antisense Nucleic Acids. Top assignees: National Center of Neurology and Psychiatry, Nippon Shinyaku Company, Ltd., Toyo Boseki Kabushiki Kaisha. Active years: 2006-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ohtsu, JP (2006 - 2011)
- Tsukuba, JP (2015 - 2021)
- Ibaraki, JP (2016 - 2024)
Company Filing History:
17 out of 43 
17 out of 229 
2 out of 789 Years Active: 2006-2024
Areas of Expertise:
Title: Naoki Watanabe: Innovator in Antisense Nucleic Acids
Introduction: Naoki Watanabe, based in Tsukuba, Japan, is a prominent inventor holding a total of 17 patents. His work primarily focuses on advancements in antisense nucleic acids, contributing significantly to the field of molecular biology and medicine.
Latest Patents: Among his latest patents is a groundbreaking invention related to antisense nucleic acids. This innovation provides a drug designed for highly efficient exon skipping. The invention includes an antisense oligomer that connects two or more unit oligomers targeting sequences that are neither consecutive nor overlapping within the same exon. This approach has the potential to advance therapeutic options for various genetic conditions.
Career Highlights: Naoki Watanabe has made significant contributions to his field while working at notable institutions including Nippon Shinyaku Company, Ltd. and the National Center of Neurology and Psychiatry. His research has focused on innovative solutions that can potentially enhance the effectiveness of treatments for patients.
Collaborations: Throughout his career, Watanabe has collaborated with esteemed colleagues such as Shin'ichi Takeda and Tetsuya Nagata. These collaborations have fostered an environment of shared knowledge and expertise, furthering the progress of molecular research.
Conclusion: Naoki Watanabe stands out as a significant figure in the realm of inventions associated with antisense nucleic acids. His comprehensive body of work exemplifies the impact of innovation in the medical and scientific communities, paving the way for future advancements in genetic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile